Literature DB >> 22275100

Draft genome sequence of probiotic strain Lactobacillus rhamnosus R0011.

Thomas A Tompkins1, Guillaume Barreau, Vanessa G de Carvalho.   

Abstract

Lactobacillus rhamnosus R0011 is a commercially available probiotic that is widely used in human dietary supplements and pharmaceutical products. We prepared a draft genome sequence consisting of 10 contigs totaling 2,900,620 bases and a G+C content of 46.7% for this strain.

Entities:  

Mesh：

Year:  2012        PMID： 22275100      PMCID： PMC3272942          DOI： 10.1128/JB.06584-11

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  6 in total

Review 1.  A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011.

Authors:  L M Foster; T A Tompkins; W J Dahl
Journal:  Benef Microbes       Date:  2011-12-01       Impact factor: 4.205

2.  Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.

Authors:  Ingemar von Ossowski; Justus Reunanen; Reetta Satokari; Satu Vesterlund; Matti Kankainen; Heikki Huhtinen; Soile Tynkkynen; Seppo Salminen; Willem M de Vos; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

3.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; Robert Whitehead; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

4.  Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; M Kay Washington; Yan Shi; LinShu Liu; Rupesh Chaturvedi; Richard M Peek; Keith T Wilson; D Brent Polk
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

5.  Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates.

Authors:  M K Salminen; H Rautelin; S Tynkkynen; T Poussa; M Saxelin; V Valtonen; A Järvinen
Journal:  Clin Infect Dis       Date:  2006-01-25       Impact factor: 9.079

6.  Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein.

Authors:  Matti Kankainen; Lars Paulin; Soile Tynkkynen; Ingemar von Ossowski; Justus Reunanen; Pasi Partanen; Reetta Satokari; Satu Vesterlund; Antoni P A Hendrickx; Sarah Lebeer; Sigrid C J De Keersmaecker; Jos Vanderleyden; Tuula Hämäläinen; Suvi Laukkanen; Noora Salovuori; Jarmo Ritari; Edward Alatalo; Riitta Korpela; Tiina Mattila-Sandholm; Anna Lassig; Katja Hatakka; Katri T Kinnunen; Heli Karjalainen; Maija Saxelin; Kati Laakso; Anu Surakka; Airi Palva; Tuomas Salusjärvi; Petri Auvinen; Willem M de Vos
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205
  6 in total
  2 in total

1.  Phenotypical analysis of the Lactobacillus rhamnosus GG fimbrial spaFED operon: surface expression and functional characterization of recombinant SpaFED pili in Lactococcus lactis.

Authors:  Johanna Rintahaka; Xia Yu; Ravi Kant; Airi Palva; Ingemar von Ossowski
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

2.  A comparative pan-genome perspective of niche-adaptable cell-surface protein phenotypes in Lactobacillus rhamnosus.

Authors:  Ravi Kant; Johanna Rintahaka; Xia Yu; Pia Sigvart-Mattila; Lars Paulin; Jukka-Pekka Mecklin; Maria Saarela; Airi Palva; Ingemar von Ossowski
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.